• 1. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 2. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 3. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 4. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 5. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565

• Solvents and Organic Chemicals Organic Compounds Alcohol/Ether

Recent Advances in the Study of (1R,2S)-2-aminocyclopentanol;hydrochloride (CAS: 137254-03-6) in Chemical Biology and Pharmaceutical Research

The compound (1R,2S)-2-aminocyclopentanol;hydrochloride (CAS: 137254-03-6) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This research brief aims to synthesize the latest findings related to this compound, focusing on its synthesis, biological activity, and potential applications in drug development.

Recent studies have highlighted the importance of (1R,2S)-2-aminocyclopentanol;hydrochloride as a chiral building block in the synthesis of various bioactive molecules. Its rigid cyclopentane ring and functional groups make it an attractive scaffold for designing inhibitors of enzymes such as proteases and kinases. A 2023 study published in the *Journal of Medicinal Chemistry* demonstrated its utility in the development of novel antiviral agents, particularly against RNA viruses, by leveraging its ability to mimic natural nucleoside analogs.

In addition to its role in antiviral research, (1R,2S)-2-aminocyclopentanol;hydrochloride has shown promise in the field of neurology. A recent preclinical study investigated its potential as a modulator of neurotransmitter systems, specifically targeting GABAergic and glutamatergic pathways. The study, conducted by researchers at the University of Cambridge, reported that derivatives of this compound exhibited neuroprotective effects in models of neurodegenerative diseases, such as Alzheimer's and Parkinson's.

The synthesis and optimization of (1R,2S)-2-aminocyclopentanol;hydrochloride have also been a focus of recent research. Advances in asymmetric catalysis have enabled more efficient and scalable production of this compound, as detailed in a 2022 publication in *Organic Letters*. The study described a novel enzymatic resolution method that significantly improved the enantiomeric purity of the final product, addressing previous challenges in large-scale synthesis.

Looking ahead, the potential applications of (1R,2S)-2-aminocyclopentanol;hydrochloride extend beyond its current uses. Ongoing research is exploring its incorporation into peptide-based therapeutics and its role in targeted drug delivery systems. For instance, a collaborative study between MIT and Pfizer is investigating its use as a linker in antibody-drug conjugates (ADCs), where its stability and biocompatibility are critical factors.

In conclusion, (1R,2S)-2-aminocyclopentanol;hydrochloride (CAS: 137254-03-6) represents a versatile and valuable compound in modern pharmaceutical research. Its applications span antiviral therapy, neurology, and drug delivery, with ongoing studies likely to uncover additional therapeutic potentials. Researchers are encouraged to explore its derivatives and novel synthetic routes to further expand its utility in addressing unmet medical needs.

• 68327-04-8(trans-(1S,2S)-2-Aminocyclopentanol hydrochloride)
• 930-45-0((1S,2S)-2-Aminocyclopentanol)
• 57070-95-8(cis-2-aminocyclopentanol)
• 31889-37-9(cis-2-aminocyclopentanol;hydrochloride)
• 31775-67-4(trans-2-aminocyclopentanol;hydrochloride)
• 59260-76-3(trans-2-aminocyclopentanol)
• 68327-11-7((1R,2R)-2-aminocyclopentanol;hydrochloride)
• 225791-13-9((1S,2R)-2-aminocyclopentan-1-ol hydrochloride)
• 260065-85-8((1R,2S)-2-aminocyclopentan-1-ol)
• 89381-13-5(2-Aminocyclopentanol)